Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.

Interleukin-2 (IL-2) treatment induces other cytokines such as tumour necrosis factor (TNF) TNF may mediate some of the anti-tumour activity of IL-2, but conversely, may contribute to its dose limiting toxicities. Cleaved extracellular domains of the p55 and the p75 TNF receptors (sTNF-R1 and R2) bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miles, D. W., Aderka, D., Engelmann, H., Wallach, D., Balkwill, F. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978036/
https://www.ncbi.nlm.nih.gov/pubmed/1333789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978036/
https://www.ncbi.nlm.nih.gov/pubmed/1333789

Ejemplares similares